Literature DB >> 22798089

Pulmonary arterial hypertension associated with neurofibromatosis type 1.

Miguel F Carrascosa1, Isabel Celemín Larroque, Juan-Luis García Rivero, José-Antonio Saiz-Quevedo García, Marta Cano Hoz, Miguel Ares Ares, Xabier Arrastio López, José-Ramón Salcines Caviedes.   

Abstract

The authors report a case of severe pulmonary arterial hypertension (PAH) in a 75-year-old woman who had received a diagnosis of neurofibromatosis type 1 (NF1) 23 years before. She presented with progressive dyspnoea and recurrent syncope. Even though the patient initially improved after starting supportive and specific treatment for PAH, she then deteriorated and died from respiratory failure 11 months after the diagnosis of PAH. Prompt recognition of such an unusual association between PAH and NF1 and appropriate therapeutic intervention could ameliorate quality of life and prolong survival in this patient population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22798089      PMCID: PMC3029927          DOI: 10.1136/bcr.05.2010.2961

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

1.  [Pulmonary hypertension in a patient with neurofibromatosis].

Authors:  Francisco José García Hernández; Julio Sánchez Román; Celia Ocaña Medina; Luis Mateos Romero
Journal:  Med Clin (Barc)       Date:  2002-01-26       Impact factor: 1.725

Review 2.  Von Recklinghausen's neurofibromatosis: neurofibromatosis type 1.

Authors:  R M Reynolds; G G P Browning; I Nawroz; I W Campbell
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

Review 3.  Pulmonary arterial hypertension.

Authors:  Harrison W Farber; Joseph Loscalzo
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

4.  Pulmonary hypertension and interstitial fibrosis in von Recklinghausen neurofibromatosis.

Authors:  J K Porterfield; R E Pyeritz; T A Traill
Journal:  Am J Med Genet       Date:  1986-11

5.  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.

Authors: 
Journal:  Arch Neurol       Date:  1988-05

Review 6.  Pharmacotherapeutic management of pulmonary arterial hypertension.

Authors:  Joe R Anderson; James J Nawarskas
Journal:  Cardiol Rev       Date:  2010 May-Jun       Impact factor: 2.644

Review 7.  Pulmonary arterial hypertension: an update on diagnosis and treatment.

Authors:  Richard Stringham; Nipa R Shah
Journal:  Am Fam Physician       Date:  2010-08-15       Impact factor: 3.292

8.  von Recklinghausen disease complicated by pulmonary hypertension.

Authors:  Y Aoki; M Kodama; T Mezaki; R Ogawa; M Sato; M Okabe; Y Aizawa
Journal:  Chest       Date:  2001-05       Impact factor: 9.410

Review 9.  Clinical and genetic aspects of neurofibromatosis 1.

Authors:  Kimberly Jett; Jan M Friedman
Journal:  Genet Med       Date:  2010-01       Impact factor: 8.822

Review 10.  Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force.

Authors:  J M Friedman; Jack Arbiser; Jonathan A Epstein; David H Gutmann; Stephen J Huot; Angela E Lin; Bruce McManus; Bruce R Korf
Journal:  Genet Med       Date:  2002 May-Jun       Impact factor: 8.822

View more
  2 in total

1.  Neurofibromatosis-associated pulmonary hypertension: an ominous duo.

Authors:  Sónia Gomes Coelho; Maria José Loureiro
Journal:  BMJ Case Rep       Date:  2020-07-13

2.  An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.

Authors:  Suman Rao; Alisha Khan; Parth Sampat; Michael Sandhu; Andrew M Weinberg
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.